Inconsistencies in reporting may mean opioid deaths are undercounted

Drug-related deaths more than tripled between 1999 and 2015—and many of those can be attributed to opioids. But the numbers may be more alarming than previously thought, according to a new report from Kaiser Health News and Side Effects Public Media.

Because of inconsistent reporting and testing methods, opioid-related overdoses are undercounted by 25 and 35 percent. The numbers reflect findings from a February study in Addiction

“We have a real crisis, and one of the things we need to invest in, if we’re going to make progress, is getting better information,” said Christopher Ruhm, the author of the paper and an economist at the University of Virginia in Charlottesville.

Read more at Kaiser Health News below:

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Around the web

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met. 

When regulating AI-equipped medical devices, the FDA might take a page from the Department of Transportation’s playbook for overseeing AI-equipped vehicles. These run the gamut from assisting human drivers to fully taking the wheel. 

Kit Crancer, RBMA board member, speaks with Radiology Business about key legislative developments on the Hill that will affect the specialty.